Avaliação da suplementação de creatina em ratos com traumatismo cranioencefálico sobre a suscetibilidade a crises epilépticas

Abstract

This study presents an analysis on the effects of creatine supplementation on parameters of susceptibility to seizures induced by subconvulsant dose of pentylenetetrazol (PTZ) in an experimental rat model of traumatic brain injury (TBI). TBI is an acute neurological event that can lead to chronic neurological disease, such as epilepsy. Given the magnitude of the problem, various forms of therapy is being tested, but many have failed and yet, few take into account the susceptibility to seizures as an outcome and concentrate on a very early period of injury, getting away from the reality of patients in underdeveloped countries. Creatine is an interesting compound to be evaluated for this purpose, since it has neuromodulatory properties and may regulate synaptic plasticity in developing neurons. Thus, it became interesting to investigate whether there is any effect of creatine in this scenario. To this, creatine supplementation was held by gavage in rats subjected to fluid percussion TBI model and this supplementation began one week after TBI, once a day for four weeks. PTZ test was performed two hours after the last dose of creatine. Furthermore a similar protocol was performed to verify the persistence of the effect and secondly, to verify the acute effect of creatine, just before the PTZ test. Latency for myoclonic and tonic clonic seizures, total time of generalized seizure as the clinical severity through the scale of Racine were measured and also epileptiform discharges and spindle activity before and after the administration of PTZ were quantified. As main results, it was found a decreased susceptibility to seizures in rats supplemented by a month, and the effect remained even if there was withdrawal of creatine for a week, however, this effect was not observed in the single dose of the compound. Still, a positive correlation between epileptiform discharges and spindle activity was found, both reduced in animals supplemented continuously. Thus, creatine is presented as a candidate to be tested in studies with TBI, with the purpose of reducing the susceptibility to seizures.